Quick Answer
HCA Healthcare, Inc. reported Total Revenue of $75.60 billion for fiscal year 2025.
HCA Healthcare, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $75.60B +7.1% |
$70.60B +8.7% |
$64.97B +7.9% |
$60.23B +2.5% |
$58.75B +14.0% |
$51.53B +0.4% |
| Net Income | $6.78B +17.8% |
$5.76B +9.9% |
$5.24B -7.1% |
$5.64B -18.9% |
$6.96B +85.3% |
$3.75B +7.1% |
| Diluted EPS | $28.33 +28.8% |
$22.00 +16.0% |
$18.97 -0.9% |
$19.15 -9.5% |
$21.16 +93.6% |
$10.93 +8.5% |
| Total Assets | $60.72B +2.0% |
$59.51B +5.9% |
$56.21B +7.2% |
$52.44B +3.3% |
$50.74B +6.8% |
$47.49B +5.4% |
| Cash and Equivalents | $1.04B -46.2% |
$1.93B +106.7% |
$935.00M +3.0% |
$908.00M -37.4% |
$1.45B -19.1% |
$1.79B +188.7% |
| Long-Term Debt | $41.60B +8.5% |
$38.33B +3.1% |
$37.17B -1.4% |
$37.71B +9.8% |
$34.34B +11.5% |
$30.80B -8.3% |
| Stockholders Equity | -$6.03B -141.2% |
-$2.50B -40.9% |
-$1.77B +35.9% |
-$2.77B -196.6% |
-$933.00M -263.1% |
$572.00M +120.4% |
| Shares Outstanding | 224.61M -10.2% |
249.98M -5.9% |
265.54M -4.3% |
277.38M -9.2% |
305.48M -10.0% |
339.43M +0.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $19.16B | +9.6% | +3.0% |
| Net Income | September 30, 2025 | $1.64B | +29.4% | -0.6% |
| Diluted EPS | September 30, 2025 | $6.96 | +42.6% | +1.9% |
| Total Assets | September 30, 2025 | $59.75B | +0.5% | +0.4% |
| Cash and Equivalents | September 30, 2025 | $997.00M | -65.5% | +6.2% |
| Long-Term Debt | September 30, 2025 | $38.40B | +0.3% | -2.5% |
| Stockholders Equity | September 30, 2025 | -$5.33B | -144.5% | -21.4% |
| Shares Outstanding | September 30, 2025 | 229.85M | -9.7% | -2.7% |
- HCA Healthcare, Inc. reported Total Revenue of $75.60 billion for fiscal year 2025.
- HCA Healthcare, Inc. showed an increase of +7.1% in Total Revenue compared to the prior fiscal year.
- HCA Healthcare, Inc. reported Net Income of $6.78 billion for fiscal year 2025.
- HCA Healthcare, Inc. showed an increase of +17.8% in Net Income compared to the prior fiscal year.
- HCA Healthcare, Inc. reported Diluted EPS of $28.33 per share for fiscal year 2025.
- HCA Healthcare, Inc. showed an increase of +28.8% in Diluted EPS compared to the prior fiscal year.
- HCA Healthcare, Inc. reported Total Assets of $60.72 billion for fiscal year 2025.
- HCA Healthcare, Inc. showed an increase of +2.0% in Total Assets compared to the prior fiscal year.
- HCA Healthcare, Inc. reported Cash and Equivalents of $1.04 billion for fiscal year 2025.
- HCA Healthcare, Inc. showed a decrease of -46.2% in Cash and Equivalents compared to the prior fiscal year.
- HCA Healthcare, Inc. reported Long-Term Debt of $41.60 billion for fiscal year 2025.
- HCA Healthcare, Inc. showed an increase of +8.5% in Long-Term Debt compared to the prior fiscal year.
- HCA Healthcare, Inc. reported Stockholders Equity of -$6.03 billion for fiscal year 2025.
- HCA Healthcare, Inc. showed a decrease of -141.2% in Stockholders Equity compared to the prior fiscal year.
- HCA Healthcare, Inc. reported Shares Outstanding of 224.61 million shares for fiscal year 2025.
- HCA Healthcare, Inc. showed a decrease of -10.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: